Profound Medical Corp. (PROF)
NASDAQ: PROF · Real-Time Price · USD
4.463
-0.037 (-0.83%)
Sep 3, 2025, 10:27 AM - Market open

Profound Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Operating Revenue
3.142.440.3923.154.58
Upgrade
Other Revenue
8.78.246.814.683.722.72
Upgrade
11.8410.687.26.686.877.3
Upgrade
Revenue Growth (YoY)
59.81%48.35%7.75%-2.79%-5.90%74.99%
Upgrade
Cost of Revenue
3.623.642.893.663.923.83
Upgrade
Gross Profit
8.227.044.313.022.953.47
Upgrade
Selling, General & Admin
30.8223.1318.5417.9317.9712.43
Upgrade
Research & Development
19.7216.9714.4214.6915.289.91
Upgrade
Operating Expenses
50.5440.132.9632.6233.2422.34
Upgrade
Operating Income
-42.32-33.06-28.65-29.6-30.29-18.86
Upgrade
Interest Expense
----0.17-0.07-0.54
Upgrade
Interest & Investment Income
1.341.440.780.80.210.69
Upgrade
Currency Exchange Gain (Loss)
0.293.81-0.583.1-0.29-2.54
Upgrade
Other Non Operating Income (Expenses)
---0.02-0.16-0.24
Upgrade
EBT Excluding Unusual Items
-40.69-27.82-28.45-25.86-30.59-21.49
Upgrade
Impairment of Goodwill
----2.52--
Upgrade
Other Unusual Items
------0.09
Upgrade
Pretax Income
-40.69-27.82-28.45-28.38-30.59-21.58
Upgrade
Income Tax Expense
0.04-0-0.130.290.110.05
Upgrade
Net Income
-40.73-27.82-28.32-28.67-30.7-21.62
Upgrade
Net Income to Common
-40.73-27.82-28.32-28.67-30.7-21.62
Upgrade
Shares Outstanding (Basic)
282521212017
Upgrade
Shares Outstanding (Diluted)
282521212017
Upgrade
Shares Change (YoY)
20.83%16.91%1.69%1.79%18.33%55.83%
Upgrade
EPS (Basic)
-1.48-1.12-1.34-1.38-1.50-1.25
Upgrade
EPS (Diluted)
-1.48-1.12-1.34-1.38-1.50-1.25
Upgrade
Free Cash Flow
-34.73-23.45-22.61-25.8-22.39-20.57
Upgrade
Free Cash Flow Per Share
-1.26-0.95-1.07-1.24-1.09-1.19
Upgrade
Gross Margin
69.43%65.89%59.90%45.22%42.95%47.56%
Upgrade
Operating Margin
-357.39%-309.57%-397.99%-443.08%-440.73%-258.26%
Upgrade
Profit Margin
-344.01%-260.45%-393.43%-429.11%-446.66%-296.03%
Upgrade
Free Cash Flow Margin
-293.35%-219.60%-314.06%-386.17%-325.80%-281.68%
Upgrade
EBITDA
-41.56-32.13-27.72-28.83-29.61-18.36
Upgrade
EBITDA Margin
------251.34%
Upgrade
D&A For EBITDA
0.760.940.930.780.680.51
Upgrade
EBIT
-42.32-33.06-28.65-29.6-30.29-18.86
Upgrade
EBIT Margin
------258.26%
Upgrade
Revenue as Reported
11.8410.687.26.686.877.3
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q